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Background:MMP-13 recognizes poorly-defined sequences in collagens.
Results:MMP-13 binds key residues in the canonical cleavage site and another site near the collagen N terminus.
Conclusion:MMP-1 andMMP-13 differ in their recognition and cleavage of collagen, which is regulated primarily through the
Hpx domain of MMP-13.
Significance:Our data explain the preference of MMP-13 for collagen II.
Remodelingof collagenbymatrixmetalloproteinases (MMPs) is
crucial to tissue homeostasis and repair. MMP-13 is a collagen-
ase with a substrate preference for collagen II over collagens I
and III. It recognizes a specific, well-known site in the tropoco-
llagen molecule where its binding locally perturbs the triple
helix, allowing the catalytic domain of the active enzyme to
cleave the collagen  chains sequentially, at Gly775–Leu776 in
collagen II. However, the specific residues upon which collagen
recognition dependswithin and surrounding this locus have not
been systematically mapped. Using our triple-helical peptide
Collagen Toolkit libraries in solid-phase binding assays, we
found thatMMP-13 shows little affinity forCollagenToolkit III,
but binds selectively to two triple-helical peptides of Toolkit II.
We have identified the residues required for the adhesion of
both proMMP-13 andMMP-13 to one of these, Toolkit peptide
II-44, which contains the canonical collagenase cleavage site.
MMP-13 was unable to bind to a linear peptide of the same
sequence as II-44.We also discovered a second binding site near
the N terminus of collagen II (starting at helix residue 127) in
Toolkit peptide II-8. The pattern of binding of the free
hemopexin domain of MMP-13 was similar to that of the full-
length enzyme, but the free catalytic subunit bound none of our
peptides. The susceptibility of Toolkit peptides to proteolysis in
solution was independent of the very specific recognition of
immobilized peptides by MMP-13; the enzyme proved able to
cleave a range of dissolved collagen peptides.
Collagens are comprised of three chains containing repeat-
ing Gly-X-X triplets (where X and X are often Pro and Hyp,
respectively). This primary structure allows the formation of a
right-handed collagen superhelix, which endows the molecule
with resistance to degradation by most proteases. The fibrillar
collagens I, II, and III contain a conserved triple-helical COL
domain of 1014 residues, with short, non-helical extensions at
each end, which constitutes a tropocollagen molecule. Such
collagens assemble side-by-side to form a three-dimensional
staggered array (a fibril) with a regular offset of 234 residues
(one D-period) between adjacent tropocollagens. This organi-
zation gives rise to the striated structure of the collagen fiber
observed by transmission electron microscopy, where the 67
nm periodicity reflects the dimensions of one D-period (1).
Collagenolytic MMPs are members of the zinc-dependent
peptidase family whose tightly regulated proteolytic activities
play a pivotal role in extracellular matrix homeostasis, cell
migration and wound healing. Under pathological conditions,
uncontrolled tissue remodeling by collagenases such as
MMP-13 is associated with the potentiation of tumor progres-
sion and metastasis, atherosclerotic plaque remodeling and
arthritic disease (2). The preferred substrate for MMP-13 is
collagen II which is cleaved five times faster than collagen I and
six times faster than collagen III (3), and more readily by
MMP-13 than by other collagenases.
As with other MMPs, collagenases are secreted as pro-en-
zymes with an organized domain structure comprising a pro-
peptide region (cleaved to yield the active mature enzyme), a
globular, Zn2-binding catalytic domain (Cat),2 a linker region
and a C-terminal 4-bladed -propeller hemopexin-like domain
(Hpx) (4, 5). The Cat and Hpx are thought to cooperate to
recognize and bind to the cleavage site, in collagen D-period 4
(D4), three-quarters of the way along the tropocollagen mole-
cule (6, 7). Binding of the Hpx is considered to facilitate local
relaxation of the helix, allowing the Cat domain of the MMP to
hydrolyze specific Gly-X bonds within Gly-X-X, where X is
either Leu or Ile, and X is either Ala or Leu (i.e. within the
tripletG-[I/L]-[A/L]) (8). Deletion of theHpx domain therefore
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results in a loss of collagenase activity (9, 10). To date, two
cleavage sites have been identified forMMP-13 within collagen
II. The first at Gly775–Leu776 (numbering refers to position
within collagen II helical domain) is shared byMMPs-1 and -8;
the second site, Gly778–Gln779 (11) is three amino acids from
the N terminus of the newly-cleaved quarter fragment (12).
Several G-[I/L]-[A/L] triplets are present in native collagen,
indicating that, in principle, other scissile bonds may exist.
However, with the exception ofMMP-13, mostMMPs primar-
ily cleave the collagen helix at a single location, reflecting the
importance of the unique sequence which surrounds the cleav-
age site (13, 14).
To simplify structural research, a mutant species, MMP-
13(E204A), has been produced. The mutation lies within the
active site, and MMP-13(E204A) lacks catalytic activity while
retaining the same conformation. The specific collagen resi-
dues required for recognition of the collagen triple helix and the
residues within/surrounding the canonical collagenase site
described above have not yet been systematically identified, and
with this in view, we have investigated both wild type MMP-13
andMMP-13(E204A) in the present study. The use of bothwild
type and mutant active forms, together with their correspond-
ing pro-forms and a free Hpx domain allows us to investigate
the contribution to binding of all three component domains.
To facilitate mapping studies we synthesized a library of
overlapping homotrimeric host-guest peptides, in which 27
residues of primary collagen (guest) sequence is placed between
[GPP]5 hosts that ensure triple-helical conformation. The last
nine guest amino acids are the same as the first nine amino acids
in each successive peptide, and these peptide libraries (referred
to as Collagen II and III Toolkits, respectively) encompass the
entire triple helical domains of collagens II and III (15, 16),
reviewed by Farndale et al. (17). Here, we used these Toolkits to
mapMMP-13 binding to collagens II and III, and we proceeded
to synthesize subsidiary peptides to identify those residues sur-
rounding the cleavage site that are required for the binding of
MMP-13. This systematic approach has also allowed us to iden-
tify a new MMP-13 binding site on collagen type II.
The recent elucidation (7) of the structure ofMMP-1 in com-
plex with a triple-helical peptide derived from the use of the
Toolkits allows us to compare the binding activity of both col-
lagenases to their common cleavage site, and to show that there
aremarked differences between the binding activities of the two
enzymes that may account for their differing specificities for
collagens I, II, and III.
EXPERIMENTAL PROCEDURES
MMP-13 Expression, Purification, and Activation—Recom-
binant proMMP-13 was expressed and purified as previously
described (18). Where required, proMMP-13 was activated to
yieldMMP-13 by incubation in 1mM 4-amino-phenylmercuric
acetate (APMA) for 1 h at 37 °C. ProMMP-13(E204A) was
expressed inEscherichia coliBL21(DE3), refolded, purified, and
activated essentially as described for proMMP-1(E200A) (19,
20). The Cat domain of MMP-13 (249–451) was expressed
and purified from NSO mouse myeloma cells as previously
described (12). MMP-13 GST-Hpx domain was expressed in
E. coli using the pGEX-2T expression vector, the forward
primer TCCGCGTGGATCCCTCTATGGTCCAGGAGA-
TGAA and the reverse primer GCAA-ATTCCATTTTGTGG-
TGTTGAAGAATTCAT, which contain BamHI and EcoRI
restriction sites, respectively, as previously described(16).
Peptide Synthesis—Collagen Toolkit II and III and other pep-
tides were generated using an AB Systems Pioneer automated
synthesizer and N-(9-fluorenyl)methoxycarbonyl (Fmoc)
chemistry as previously described (15, 16). All peptides were
verified usingMALDI-TOFmass spectrometry and their triple-
helical conformation confirmed by polarimetry.
Peptide Design—Unless stated otherwise, all peptides were
triple-helical, a structuremaintained by the flanking sequences,
GPC(GPP)5- and -(GPP)5-GPC-amide, at their N and C termi-
nus, respectively. For simplicity, peptides are referred to by
their specific guest sequence. A negative control peptide, (GPC-
(GPP)10-GPC-amide) is referred to asGPP10.A linear version of
Toolkit peptide II-44 contained the same guest sequence
between disordered flanking host sequences, thus: GCPP(GP-
PP)2GGPPPG-II-44 guest sequence -P(GPPP)2GGPPPG-
CPG-amide.
MMP-13 Toolkit Solid-Phase Binding Assays (SPBA)—
Immulon 2HB 96-well plates (Nunc, Langenselbold, Germany)
were coatedwith CollagenToolkit or other peptides, fibrillar or
monomeric collagen at a saturating concentration (10g/ml in
0.01 M acetic acid) overnight at 4 °C. Fibrous bovine type I col-
lagen was a gift from Ethicon Corporation (Somerville, NJ).
Monomeric collagen was obtained from Devro (Bathurst, Aus-
tralia). All further incubations were performed at 24 °C for 1 h
unless otherwise stated. The wells were washed three times
with adhesion buffer (1 mg/ml BSA in Tris-buffered saline
(TBS) containing 0.1% (v/v) Tween-20) between each incuba-
tion step. The wells were blocked with 50 mg/ml BSA in TBS
prior to the addition of MMP at a concentration of 83 nM
(unless otherwise stated) in adhesion buffer. Where indicated,
increasing amounts of Toolkit peptides II-8 and II-44 were pre-
incubated for 20 min with the MMP prior to adhesion assays.
Rabbit anti-MMP-13, raised against MMP-13 hinge region
(Abcam, Cambridge, UK), and goat anti-rabbit HRP (Dako, Ely,
UK) were added at a dilution of 1:2000 in adhesion buffer prior
to the addition of TMB substrate system (Sigma), and the plates
read at 450 nm. Rabbit HRP-linked anti-GST (GE Healthcare;
dilution 1:10,000) was used to detect GST-Hpx. To confirm
affinity of the anti-hinge antibody for MMP-13 and MMP-
13(E204A), increasing concentrations of MMP were coated
onto an ELISA plate prior to blocking and detected as previ-
ously described. Binding curveswere fitted using Prism5.0 soft-
ware (GraphPad, San Diego), allowing total binding (Bmax) and
equilibrium dissociation constant (KD) to be determined.
Biotinylation ofMMP-13(E204A) and the CatDomain—Pro-
teins were C-terminally biotinylated using an EZ-LinkMicro
Sulfo-NHS-Biotinylation Kit (Pierce) according to the manufa-
cturer’s instructions. Successful biotinylation was detected via
Western blotting using an ultrasensitive Streptavidin-Peroxi-
dase Polymer (Sigma).
Peptide Digestion Assays—To determine the likelihood of
Toolkit peptide clipping by MMP-13 during SPBA experi-
ments, Toolkit peptides at a final concentration of 80 M were
incubated with a high (4.4M final) concentration ofMMP-13,
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MMP-13(E204A) or the equivalent volume of Tris buffer pH
7.4 for 1 h at 24 °C. Proteolytic activity ofMMP-13was assessed
following incubation of Toolkit peptides with 250 nMMMP for
16 h at 24 and 37 °C, respectively. The samples were then either
examined by electrophoresis under reducing conditions, with
silver staining, or submitted for MALDI mass spectrometry.
SDS-PAGE electrophoresis was performed on 4–12%NuPage
bis-Tris gels (Invitrogen) according to the manufacturer’s
instructions.
Mass Spectrometry Analysis—Peptides in TBS buffer, pH 7.4,
were reducedwith5mMTris(2-carboxyethyl)phosphine (Thermo
Scientific-Pierce) for 10 min at 35 °C and then desalted using
uC18ZipTips (Millipore) equilibrated and washed with 5% (v/v)
acetic acid. Peptides were eluted with 2l of ferulic acidmatrix
(Sigma; 10 mg/ml in 50% (v/v) aqueous acetonitrile), spotted to
theMALDI target plate, dried, andwashed once with 2l of 5%
(v/v) acetic acid. Mass spectra were collected on a MALDI
MicroMX Instrument (Waters, UK) in reflectron mode at
threshold laser power. Spectra were calibrated externally with
polyethylene glycol 1000–2000-3000 (Sigma) and then
adjusted by lockmass to one of two known peptides present in
all samples from the autodigestion of MMP-13 (20–42 and
21–42, confirmed by ms/ms as below). Mass accuracies were
generally better than 20 ppm, allowing only a single interpreta-
tion of the cleavage site for most peptides. Any ambiguities
were resolved byms/ms fragmentation on a separately desalted
sample, eluted in 70% MeOH/0.2% (v/v) formic acid, and ana-
lyzed on a Thermo LCQ Classic ion-trap instrument using
static nanospray delivery. This confirmed the sequence
identity.
RESULTS
Binding of MMP-13 to Toolkit Peptides and Collagen—Using
SPBA we show that wild type MMP-13, in both its active and
pro-enzyme form, bound prominently to just two peptides,
II-44 and II-8, with trace binding activity to peptide II-7 (Fig.
1A). Binding of MMP-13 to II-44 was slightly stronger than to
II-8 with A450 values of 0.7 and 0.6, respectively. Toolkit III
showed uniform absence of binding (data not shown), consis-
tent with the greater activity of the enzyme against collagen
II(18). Fibrous collagen I bound wild type MMP-13 strongly
(A450 1.0), while control peptides and uncoated wells showed
the expected low reactivity (A450  0.1). Using wild type,
MMP-13 exhibited lower binding than proMMP-13 to Toolkit
peptides.
MMP-13(E204A) and proMMP-13(E204A) also bound
Toolkit II, with II-44 and II-8 clearly resolved, again with slight,
significant binding to II-7. MMP-13(E204A) was less selective
than proMMP-13(E204A), binding several other peptides (II-
13, II-17, II-21, II-45, and II-49 to II-56, with A450  0.3; Fig.
1B). ProMMP-13(E204A) was constitutively less active overall.
This rank order of binding contrasts with that of the wild type
enzyme, where the converse applied.MMP-13(E204A), but not
proMMP-13(E204A), displayed higher background binding
(A450  0.3) on Toolkit III and bound to several peptides,
including III-44 that contains the canonical cleavage site, with
low to intermediate affinity (A450 0.2–0.8; data not shown).
This may suggest that the Cat, which contains the disabling
Ala substitution, helps to define binding specificity. Lower
binding of proMMP-13(E204A)might suggest that obstruction
by the pro-domain restricts access of collagen to the enzyme,
diminishing but not abolishing its ability to bind. The lower
apparent binding of the active wild typeMMP-13might be due
either to inhibition of binding by residual pro-domain peptides,
as previously observed (21, 22) or by autolysis, effects that
appear to predominate in the active enzyme.
Binding Affinity to II-44 and II-8—We applied increasing
concentrations of the MMP preparations to peptides II-8 and
II-44 to compare binding affinities using SPBA. The linear pep-
tide equivalent to II-44 supported negligible binding of any
MMP-13 preparation (data not shown), contrasting with the
ability of a similar peptide (23, 24) to support the binding of
fibronectin, which recognizes the same site (25, 26). Compari-
son of the pro-forms of the enzyme on both triple-helical pep-
tides suggests broadly similar affinities (p  0.37), with KD
ranging from 130 to 380 nM, the latter figure (the only outlying
value) being the estimate for proMMP-13(E204A) binding to
peptide II-8 (data not shown).
Our Toolkit and SPBA data indicate that both the pro and
active forms of MMP-13 bind more strongly to II-44 than II-8.
To investigate the relative affinities of these interactions, we
pre-incubated MMP-13(E204A) with II-8 and II-44 ranging
from0.5 to 50g/ml and thenmeasured binding in SPBA to the
same immobilized peptides. Consistent with the data above,
each peptide in solution blockedMMP-13(E204A) adhesion to
its own immobilized form (Fig. 2A), with II-44 showing IC508
g/ml, and II-8 about a 4-fold weaker inhibition. II-8 caused
very slight inhibition of adhesion to II-44 at up to 50 g/ml
(extrapolated IC50 150g/ml) while II-44was a potent inhib-
itor of binding to II-8 (IC50  0.5 g/ml). These data confirm
II-44 as a more potent ligand forMMP-13 than II-8 (p 0.017,
Kruskal-Wallis test).
It was noted that Bmax was dependent on the presence of the
active site mutation, being roughly double in the proMMP-
13(E204A) andMMP-13(E204A)mutant forms compared with
their wild type counterparts (p 0.02, 2-wayANOVA, Fig. 2B).
This was not due to different recognition of wild type and
MMP-13(E204A) by the detecting antibody (data not shown).
Binding to Full-length Collagen I—Active forms of MMP-13
and MMP-13(E204A) were used in similar assays to establish
the ability of the enzyme to bind fibrillar andmonomeric colla-
gens (Fig. 3). Both enzyme preparations exhibited much lower
binding to saturated coatings of monomeric collagen I than to
II-44. This may reflect the lower density of binding sites in
monomeric collagen, where there are two sites per 1000 resi-
dues, compared with one site per 63 residues in these Toolkit
peptides. The two substrates are directly comparable, since
rotary shadowing/transmission electron microscopy (27) sug-
gests that monomeric collagens lie flat upon a surface, as would
also be anticipated for the much shorter Toolkit peptides.
Our data suggest that the binding of the MMP to collagen is
greatly facilitated by fibrillar conformation (KD40 nM). Pugh
et al. have shown that collagen fibers as used here form a com-
plex meshwork that extends tens of microns above the coated
surface (28), offering a large binding area. The observed
Sequence Requirements within Collagen II for Recognition byMMP-13
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higher affinity implies co-operative binding to discrete sites
within the fiber network. Possibly, a new composite binding
site comprising the canonical site and sequences in the adja-
cent tropocollagen molecules within a single fiber might also
generate a larger footprint on the fiber surface, and hence
higher affinity.
Binding of Cat and Hpx Toolkit Peptides II-8 and II-44—To
determine whether the MMP-13 Cat and Hpx domains were
FIGURE 1.Adhesion ofMMP-13 preparations to Collagen II Toolkit peptides. Plates were coated with 10g/ml Toolkit II peptides, fibrillar type I collagen,
and the negative binding peptide GPP10. A, proMMP-13 (black bars) andMMP-13 (gray bars). B, proMMP-13(E204A; black bars) andMMP-13(E204A; gray bars).
C, Hpx at a concentration of 83 nM were allowed to adhere to the peptides for 1 h at 24 °C. Full-length MMP-13 preparations were then detected using an
antibody directed at the MMP-13 linker region, and Hpx with an anti-GST antibody as described under “Experimental Procedures.” Data represent mean
A450 S.E. of four experiments. For reference, collagenD-periods corresponding to thesepeptides are shownasgray barsbelow, and the collagenase cleavage
site indicated by an arrow.
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individually able to recognize Toolkit peptides, their binding
was assessed in SPBA. Though the Cat domain was able to
recognize collagen, it was unable to bind to any Toolkit II pep-
tides (data not shown), while Hpx bound well to peptide II-44
(A450 0.8) and weakly to II-8 (A450 0.2; Fig. 1C). Both
domains bound fibrillar collagen I, albeit weakly in the case of
the Cat domain.
Ala-scanning of II-44—To explore the primary sequence
determinants of MMP-13 binding to II-44 in SPBA, we made a
set of truncated and alanine-substituted (Ala-scanned) triple-
helical peptides of the same general host-guest form. The data
are shown in Fig. 4. Binding of (MMP-13(E204A), and to a
lesser extent wild-type MMP preparations, proMMP-13
(E204A), andHpxwas supported by an 18-residue triple-helical
peptide, II-44A, which lacked only the three C-terminal triplets
of II-44. Peptide 44B, containing only these missing triplets,
GFOGLOGPS, supported no binding. Successive omissions of
triplets (peptides II-44C to II-44I) from both the N and C ter-
minus of II-44A each modulated the binding of MMP-
13(E204A), indicating that further truncation was inappropri-
ate. These findings were used to define the C terminus of the
Ala-scanned sequence, culminating in the addition of a single-
triplet native sequence extension, GPQ, to the N-terminal
boundary of II-44, thus creating a 21-residue peptide (44J).
Using the nomenclature of Schechter and Berger to define the
distance from the cleavage site, peptide 44J, GPQGLAGQR-
GIVGLOGQRGER, stretched fromP4 to P17where P1, preced-
ing the scissile bond, is the first (Gly) residue of the guest
sequence of peptide II-44.
As with II-44, binding to 44J differed among MMP-13
preparations, with MMP-13(E204A) binding most strongly
(A450 0.8), then proMMP-13, then proMMP-13(E204A),
then active MMP-13, and lastly the Hpx domain alone (A450
0.4). All MMP-13 preparations yielded data that allowed us
to discriminate between the Ala-substituted peptides.
Three residues were uniformly essential for binding, P8(V),
P14(R) and P17(R). No other Ala-substitutions perturbed the
binding of MMP-13(E204A), consistent with less rigorous
determinants of peptide binding to this mutant form, but sev-
eral residues were important for the binding of the other MMP
preparations including theHpx domain. P4(Q), P5(R), P10(L),
and P11(O) all fall into this category, while P1(L) was similarly
important for the binding of Hpx, and to a lesser extent
MMP-13 and proMMP-13(E204A).
Two residues in particular in the parent peptide, P13(Gln)
and P16(Glu), appeared to exert a restrictive effect, since
MMP-13 binding increased after Ala-substitution. Further res-
idues, P3(Pro), P2(Gln) and P7(Ile), showed a similar tendency
with some but not all MMP-13 preparations. These data sug-
gest that recognition of the native sequence is poised between
firm binding and release of the enzyme, perhaps allowing some
freedom to re-organize or to permit relaxation of the triple-
helical structure prior to cleavage, or to ensure release of the
enzyme once the substrate is cleaved.
FIGURE2.Competitive inhibitionofMMP-13adhesion toToolkitpeptides II-8and II-44.A,MMP-13orMMP-13(E204A)werepre-incubatedwith increasing
amounts of Toolkit peptides II-8 and II-44 prior to adhesion assays on II-8 and II-44, respectively. Absorbance was measured at 450 nm. Data represent the
mean S.E. of four experiments. B, effect ofMMP-13(E204A)mutation on increased proMMP-13 adhesion to Toolkit peptides II-8 and II-44. Binding ofMMP-13
and MMP-13(E204A) to coated ELISA wells was performed as described in Fig. 1. Both pro- and active forms of the enzyme exhibited broadly similar affinities
(p 0.37), with KD ranging from 130 to 380 nM. Data represent the mean S.E. of four experiments.
FIGURE 3. Binding of MMP-13 and MMP-13(E204A) to monomeric and
fibrillar type I collagens. Binding of MMP-13 and MMP-13(E204A) to col-
lagen-coated ELISA wells was performed as described in Fig. 1. For
MMP-13 binding to fibers and monomers, KD values were 33 and 118 nM,
respectively, and for MMP-13(E204A), 52 and 26 nM, respectively. Data
points represent the mean  S.E. of four experiments, and differences
were not significant.
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Like the intact forms of the enzyme,Hpx only bound toToolkit
peptides II-8 and II-44 in the static adhesion assays (Fig. 1C). The
adhesion profile of theHpx domain to II-44Ala-scanned peptides
reflected that of the intact enzyme(s), indicating that it is primarily
the Hpx domain, which defines the recognition of the intact
enzyme to the collagenase cleavage site of collagen II.
Proteolysis of Toolkit Peptides—We first considered the pos-
sibility that poor binding of active MMP-13 to peptides or col-
FIGURE 4.Adhesion of proMMP-13,MMP-13, proMMP-13(E204A),MMP-13(E204A), and theHpx domain to II-44 variant Toolkit peptideswas carried
out as described for Fig. 1. The dashed line representsMMPadhesion level on peptide II-44J, and the solid lineMMPbaseline adhesion onpeptide II-44B. Data
represent the mean S.E. of four experiments.
TABLE 1
Mass analysis of degraded Toolkit peptides
Following degradation for 16 h at 24 °C and 37 °C as described for Fig. 9, B and C, respectively, Toolkit peptides incubated with MMP-13 or Tris buffer were subjected to
MALDI mass spectrometric analysis to determine the peptide cleavage site(s) of MMP-13. Cleavage sites are summarized with the site of proteolysis after the first
highlighted residue.
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lagen might reflect proteolysis and release from the 96-well
surface during SPBA, leading to loss of apparent binding activ-
ity. Our binding data also suggested that peptide II-8 may offer
a novel cleavage site for MMP-13. We therefore investigated
the ability of MMP-13 to cleave several triple-helical peptides,
selected by their differing ability to bindMMP-13(E204A). Pep-
tides II-44 and II-8 (high-affinity), III-5 and III-40 (intermedi-
ate affinity), and II-24 and II-28 (non-binding), were incubated
with a high concentration (4.4 M) MMP-13 for 1 h at 24 °C,
then examined using SDS gel electrophoresis as described. The
migration of the peptides was slower than their mass would
suggest, an observation which is well known. The actual masses
of the peptides are shown in Table 1. No proteolysis of any
Toolkit peptide was observable after 1 h at 24 °C (data not
shown), despite the rather high enzyme concentration used,
allowing us to conclude that our binding assays were not
compromised by substrate degradation. As expected, MMP-
13(E204A) (and buffer control) proved unable to degrade
any peptide under any condition tested in the present study.
However, following incubation of the peptides with 250 nM
MMP-13 for 16 h at 24 °C, a temperature at which the majority
of each peptide is folded as a triple helix, proteolysis of II-8,
II-44, II-24, and III-5 was detectable by mass spectrometry.
Cleavage sites are shown in Table 1. Degradation was slight and
not detectable using SDS-PAGE (Fig. 5A). At 37 °C, proteolysis
was clearly observable by SDS-PAGE for all peptides tested (Fig.
5B). Cleavage sites were subsequently confirmed by MALDI
mass spectrometry (Table 1). At 24 °C, peptide II-44 was spe-
cifically cleaved at both its primary and secondary collagenase
cleavage sites (GL and GQ, respectively). Peptide II-8 was
cleaved, but at a GA bond downstream from the expected
GL cleavage site. At 37 °C, however, the degradation of II-44
was increasinglymarked and less specific, most likely due to the
gelatinase activity of MMP-13.
DISCUSSION
Weused four full-lengthMMP-13 preparations to screen the
Toolkit peptides; thewild type pro-form expressed and purified
frommousemyeloma cells, and recombinantMMP-13(E204A)
and proMMP-13(E204A) expressed in pET3 cells as previously
described (18, 20). The active wild type MMP-13 was prepared
by APMA-induced cleavage of its pro-form (18, 29). In addi-
tion, we tested the binding properties of recombinant Cat and
Hpx domains. The present work shows that collagen and two
triple-helical Toolkit peptides, II-44 and II-8, support firm
adhesion of MMP-13 in both its active and pro- forms, and of
the equivalent catalytically inactive mutant forms, proMMP-
13(E204A) and MMP-13(E204A). Cat bound weakly to colla-
gen, but not to anyToolkit peptide,whileHpxbound to II-8 and
to a greater extent II-44, much like proMMP-13(E204A).
The Fidelity of MMP-13(E204A) Substrate Recognition—The
use of MMPs that are alanine-substituted at the catalytic site
simplifies structural and binding studies, since both autolysis
and digestion of adhesive substrates are avoided. Here, we
observe differences in behavior of the active conformation of
MMP-13(E204A) compared with either its own pro-form or
both the active or pro-forms of the wild type enzyme. We find
MMP-13(E204A) to bind less specifically toToolkits, with extra
hits observed in Toolkit II and a noisy pattern of binding to
Toolkit III. MMP-13(E204A) was less sensitive to Ala-scanning
of peptide II-44, notably at P5, P10, and P11 (Fig. 4). In con-
trast, proMMP-13(E204A) behaved exactly as pro- or active
wild type. We also found a 2-fold higher Bmax for MMP-
13(E204A), which implies twice the number of molecules bind-
FIGURE 5. Analysis of degradation of Toolkit peptides by active MMP-13. Toolkit peptides at a final concentration of 80 M to which MMP-13(E204A)
displayed high binding (II-8 and II-44; A450	 1.2); intermediate binding (Toolkit peptides III-5 and III-40; A450 0.5–0.8) and low binding (Toolkit peptides II-24
and II-28; A450 0.2) were incubated with Tris buffer, MMP-13 or MMP-13(E204A) at 250 nM final concentration at (A) 24 °C for 16 h and (B) 37 °C for 16 h. After
incubation, samples were subjected to electrophoresis under reducing conditions and silver stained. Images are representative of three experiments.
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ing per peptide. In turn, this observation suggests dimerization
in situ, the first immobilized copy of MMP-13(E204A) recruit-
ing a second molecule, a process mediated by interactions
remote from the peptide-binding surface of the enzyme. Crys-
tallographic analysis by Stura et al. (22) indicates close agree-
ment between the structures of native and mutant forms, but
they also report MMP-13(E204A) to be monomeric in solution
despite observing dimerization in their crystal structure, medi-
ated by the Hpx domain. Reconciling these findings suggests
that the E204A substitution subtly modulates the relationship
between the Cat and Hpx domains in the active conformation
of the enzyme, in a way that renders the Hpx less selective in
recognizing collagenous substrates.
Collagen Residues Critical for Recognition by MMP-13—
Binding ofMMP-13 to peptide II-44 was expected, since it con-
tains the known collagenase cleavage site near the N terminus
of collagen D-period 4, whereas the prominent but lower affin-
ity ofMMP-13 for II-8 was unsuspected; its sequence occurring
in the center of D-period 1 (see Fig. 6). Equilibrium binding
studies suggest similar affinities of all theMMP forms tested for
II-44, withKD on the order of 200–400 nM.Ala-scanning of 44J,
a shorter peptide derived from II-44, revealed several residues
that make important contributions to the binding of MMP-13,
i.e. that Ala-substitution diminishes binding. Five of these lie
within the C-terminal half of the guest sequence of the peptide,
P8(V), P10(L), P11(O), P14(R), and P17(R). Conversely, sub-
stitution of two further residues in this region P13(Q) and
P16(E) enhanced the binding of all MMP-13 preparations.
These observations underline the importance of this tract of the
peptide in securing MMP-13 binding, and clarify the basis for
its interaction with peptide II-8. II-8 shares just three critical
residues with II-44, corresponding to P1(L), P5(R) and P17(R),
but in addition, contains two alanine residues, corresponding to
P13 andP16. Ala-substitution of both residues in peptide II-44J
enhancedMMP-13 binding. Good binding of II-8, especially in
the region predicted to bind Hpx, might therefore be
anticipated.
The Importance of Hpx in MMP-Collagen Interaction—The
distance of many of these residues from P1P1 suggests that
the Hpx domain is the main contributor to MMP-13 binding,
investigated further using isolated Hpx, which bound to both
II-8 and II-44, exactly echoing the adhesion profile of proMMP-
13(E204A) on the Ala-scanned peptide set (Fig. 4). These data
suggest a second site of interaction for Hpx in II-44. In the first,
“productive” mode of binding, Hpx engages residues P10 to
P17, GLOGQRGER, which would align the scissile P1P1
(GL) bond close to the catalytic site. The inhibition of Hpx
binding by Ala-scanning at P1, P4, and P5 indicates that these
conserved residues, GLAGQRGIV, can also interact directly
with the Hpx domain, offering a second locus that can recruit
MMP-13 to the environs of its site of action. In this case how-
ever, alignment of theCatwith P10–P9would not be productive,
as the proline-rich collagen sequence at this location would
restrict local unwinding by the MMP-13 enzyme.
Comparison ofMMP-13 withMMP-1—Our interpretation is
informed by the crystal structure of the complex between
MMP-1 and a triple-helical peptide derived from II-44J. Inspec-
tion of the MMP-1-peptide co-crystal shows that P8 and P10
interact with the proximal rim of the Hpx -propeller, binding
to the interface between blades 1 and 2, with the distal rim of
Hpx tilted away from the axis of the peptide. No interactions
were observed beyond P11. Only two peptide residues, P1(L)
and P10(L), hadmeasurable effects on binding ofMMP-1 using
a very similar SPBA, while effects of substitutions distal to P10
were negligible. In contrast, usingMMP-13, there were obvious
effects of Ala-substitutions from P10(L) to P17(R), suggesting
that its Hpx enjoys a closer interaction with regions of the pep-
tide extending further away from the scissile GL bond.
Another marked difference between the two enzymes is that
proMMP-1 did not bind to collagen or Toolkit peptides, with
the pro-domain apparently impeding access to the Cat (7, 31),
preventing the critical P1 interaction with substrate. How can
MMP-13 avoid this constraint? Superposition of the Cat
domains from the crystal structures of full-length MMP-1 and
MMP-13 by Stura et al. illustrates the different Cat-Hpx inter-
face in the two enzymes. The twodomainsmove closer together
in MMP-13, with Hpx rotated relative to Cat by 30°. The
effect is to move the collagen-binding S10 pocket of MMP-13
by about 7Å relative to that ofMMP-1(22). Thismight facilitate
collagen-proMMP-13 binding without displacement of pro-
domain from the S1 site. Like MMP-13, both proMMP-3 and
proMMP-9 can bind collagen (32). Alternatively, although acti-
vation ofMMPs is achieved through proteolytic cleavage, inter-
action with substrate may also displace the pro-domain from
the active center of the enzyme (33). Nonetheless, our SPBA
data suggests that the pro-domain does impede collagen bind-
ing to some degree: while the two full-length pro-forms of
MMP-13 showed similar binding, the catalytically dead MMP-
TABLE 2
Summary of the effect of alanine substitution onMMP-13 binding
Residues of Toolkit peptide II-44J are listed along with the residues of MMP-1 that
interact with these amino acids. (MMP-1 residues in bold are conserved in MMP-
13.) The effect of alanine substitution of each residue is annotated as:ND, not done;

 , residue lies upstream of guest sequence in peptide II-44J; –––, ––, reduction of
MMP-13 binding to peptide by  50%, and  25%, respectively; 0 is no observed
change in MMP-13 adhesion to peptide; , , increase in MMP-13 binding of
25–0% and 25%, respectively.
Position Residue
Effect of Ala
substitution on
MMP-13 binding
Residues of MMP-1 in
contact with peptide

P5 
O 
ND 
Phe166
P4 G ND
P3 P 0 Asn152, Gln167
P2 Q 0 Ser153, Ala163, His164
P1 G ND Asn161
P1 La – – Ala165, His203
P2 A ND Gly160, His209
P3 G ND
P4 Q ––– Asn161, Tyr218, Ser220, Tyr221
P5 R – – Tyr218, Pro219, Ser220
P6 G ND
P7 I 0 Glu294, Asn296, Val300, Phe301
P8 V ––– Arg285, Val300, Phe301
P9 G ND Arg285
P10 La ––– Ile271, Glu274, Met276, Arg285,
Phe289, Tyr290, Phe301, Trp302
P11 O ––– Arg272, Glu274, Gln335
P12 G ND
P13 Q 
P14 R –––
P15 G ND
P16 E 
P17 R – –
a Ala substitution that reduced MMP-1 adhesion relative to II-44J.
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13(E204A), lacking pro-domain, showed highest binding to
Toolkit peptides.
The Significance of the II-8 Binding Site—The presence of
this site was not expected, and its potential as a substrate for
the collagenase activity of MMP-13 appears restricted to the
GA clip observed at 24 °C. It is located at the center of II-8,
four triplets C-terminal to the more promising GLOGER
motif that aligns well with the canonical site in II-44; both
sites occur at the start of the guest sequence in their respec-
tive peptides, and in nature, P4 to P1 are GPRG and GPQG,
respectively. Q, preceding the canonical (II-44) site, is well
represented at P2 in the MEROPS database (34), while R,
preceding the optimally aligned II-8 site, occurs just 4 times
in 41 observations of MMP-13 activity against collagenous
substrates. This locus in II-8 was clipped at 37 °C, and should
not be discounted as an authentic site for the collagenolytic
activity of MMP-13.
The two sites may cooperate in recruiting MMP-13 to colla-
gen. In 2007, Overall and Butler (21) proposed an “inchworm”
model of MMP translation along the collagen molecule, based
on the “burnt bridges”molecular ratchetmodel (forMMP-1) of
Saffarian et al. (40), and the atomic force study of Rosenblum et
al. (41) on MMP-9. For this model to be generally applicable,
the MMPs would need to have affinity for long stretches of
sequence within the collagen helix, as well as the capacity for
sequence-independent cleavage of triple-helical collagen.
Manka et al. (7) found that MMP-1 lacked the ability to bind
well to any site other than II-44 in collagen II, andwe show here
that MMP-13 is only slightly less selective, binding to II-8 as
well as to the second site in II-44. The “inchworm” model may
therefore have limited validity for MMP-13, applying to trans-
location of Hpx binding from the P1 to P5 tract to P10 to P17.
The “quarter-stagger” assembly of the collagen fiber dictates
that any D-period is aligned side by side with all others (see Fig.
6). Thus, amolecule that bound at the start ofD1would be quite
close to the start of D2,D3,D4, and of the truncatedD5 (the gap
region) in adjacent tropocollagenmolecules. The simplemodel
of fiber assembly allows us to calculate the proximity of any two
sites. GLAGQR in II-44 represents residues 775–780 of the
tropocollagen helix, or 73–78 of the D-period, whereas
GLOGER in II-8 is residues 127–132 of both the helix and
D-period.Within a fiber, therefore, there is an axial offset of 54
FIGURE6.Schematic illustrationofa collagen fiber.Above shows thealternatinggap (pale) andoverlap (dark) banding, derived fromthe staggeredassembly
of the fiber from tropocollagenmolecules.Middle, the “quarter stagger” between tropocollagenmolecules is shown, with labeled D-periods alternating (gray
andwhite) with theMMP-13 binding sitesmapped onto them (black). Below the linear separation between the II-44 and II-8 sites is shown, and their sequences
provided. Key binding residues in II-44 and II-8 are larger, bold font, while restrictive residues (II-44) are in the smaller font. Lateral separation between the axes
of the tropcollagen monomers (not indicated) is of the order of 3 nm.
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residues between the two sites, corresponding to about 15 nm,
close enough, perhaps, to support some co-operativity. Inspec-
tion of the co-crystal of MMP-1 and a II-44-derived triple-heli-
cal peptide (7) suggests that an MMP can span about 25 colla-
gen helix residues, less than 10 nm. Although not contiguous,
therefore, it is plausible that hydrolysis of the canonical site
might lead to anchorage of MMP-13 by its Hpx domain to the
clipped helix, with sufficient flexibility in the clipped collagen to
relocate via its Cat to nearby II-8 sites. This “ball and chain”
model would also apply to adjacent canonical sites in D4. The
three-dimensional structure may be more complex than the
simple model (35, 36), but in either of these two, reciprocal,
renderings of the fiber, hydrolysis at one site could reveal the
other site beneath.
Finally, whether it is a cleavage site or not, it is plausible that
II-8 fulfils a depot function, acting to sequester proMMP-13 in
the collagenmatrix to be activated as required.MMP-13 differs
from MMP-1 in this respect, in that only the active form of
MMP-1 was found to bind to Toolkit II (7).
The Selectivity of MMP-13 for Different Collagens—Compar-
ison of the collagenase cleavage sites of the various fibrillar col-
lagens with the sequences of the MMP-13-binding peptides
provides a basis for their relative recognition and subsequent
cleavage. High identity occurs between 1(I) and 1(II), with
only two non-identical but conserved amino acids within the
sequence equivalent to II-44. The reported 6-fold lower activity
of MMP-13 on collagen I may therefore reside in the different
sequence at P4 and P5 in 2(I), where A and O occur in place
of Q and R, both of which, when replaced with A in peptide
II-44J, support reduced binding of active MMP-13. In collagen
III, only three (P5(R), P11(O) and P17(R)) of the eight critical
amino acids are identical with those in collagen II.We therefore
anticipate a lower affinity interaction ofMMP-13 with collagen
III, consistent with its relative resistance to proteolysis.
Toolkit Peptides as Substrates for Proteolysis by MMP-13—
We tested the ability of MMP-13 to digest six peptides during
16 h at either 24 °C or 37 °C by examining peptide fragments by
mass spectrometry. After incubation at 24 °C,we observed both
expected clips in II-44, at P1P1 and P3P4, at the canonical
and secondary sites that are well-known(12). At this tempera-
ture, only five other clips were located in the six peptides tested,
including a GA bond in II-8. We had anticipated that the
GL bond at the start of the guest sequence of II-8, equivalent
to P1P1 in II-44, might be susceptible, best aligning with the
catalytic site according to our interpretation of Ala-scan
data, but it proved otherwise. The MEROPS database (34)
describes the preferred MMP-13 cleavage sequence as being
GPxGLxGx, with proline (bold) occurring at P3 in 92 of 147
sites, P being themost abundant P3 residue in both collagenous
and non-collagenous substrates. The sequence cleaved in II-8
conforms well, the site being GPAGAA, with no other imino
acids occurring within 9 residues, which may contribute to a
more relaxed structure that facilitates proteolysis (37).
At 37 °C, all Toolkit peptides tested were cleaved by MMP-
13, irrespective of their ability to bind MMP-13(E204A) in
SPBA, and 20 different sites were identified in addition to the 7
found at 24 °C.We found four cleavedGL sites, from a total of
ten occurrences of GL in the six peptides tested. Five of these
ten were within GLO triplets, only one of which was cleaved,
suggesting that the hydroxyproline at P2 confers a protective
effect, whichmight account for the resistance of theGL bond in
II-8 to hydrolysis. We also found four GE sites, of only eight
GEx triplets within the peptides tested. Deng et al. report that
the hydrophobicMMP-13 S3 subsite has a preference for Pro in
P3 (38), and propose a consensus motif, PLGMR. Our limited
data suggest a novel consensus sequence: PPGER, with
POGAX and POGLA as alternatives. Our data concur
with that compiled in MEROPS, although GE cleavage is
only recorded twice therein, as proline occurs as P3 in 15 of
the 27 cleavage sites (55%) we report here, regardless of
temperature.
We considered why elevating temperature might increase
the number of resolvable cleavage sites. Firstly, reaction rates
will increase, but secondly, our peptides have limited thermal
stability, with melting temperatures typically of 45 °C. Thus at
37 °C a substantial proportion (18–52%), estimated for each
specific peptide and shown in Table 1, exists in unfolded, sin-
gle-stranded form (39) where, unlike native collagens, tertiary
structure no longer governs substrate specificity and MMP-13
functions as a gelatinase (30). Digestion of any single-stranded
material that is susceptible to proteolysis byMMP-13 will draw
the equilibrium in favor of unfolded peptide, leading to gradual
depletion of intact triple helix.Mass spectrometry revealed that
few of the common peptide fragments were generated by cleav-
age within the GPP hosts. This may reflect the greater thermal
stability of the relatively proline-rich host sequence, which
unfolds less readily and so presents a less frequent target for
proteolysis by MMP-13 than the guest sequence.
In summary, herewe show that, unlikeMMP-1, both the pro-
and active forms of MMP-13 are able to bind collagen, at both
the canonical MMP cleavage site, and at a second, lower-affin-
ity site located in Toolkit peptide II-8 (corresponding to D-pe-
riod 1 of the collagenmonomer).We show that the recognition
of II-44 by MMP-13 is primarily mediated by the Hpx domain
and is specified by GLXGQRmotifs at either P1-P5 or P9-P14.
By examining the cleavage of selected collagen peptides by
MMP-13, we show that hydrolysis is not confined to motifs
recognized by the Hpx domain, but is likely to include peptide
strands that are unfolded at 37 °C. These data provide a ration-
ale for the structural regulation of collagen proteolysis and the
resistance of peptide II-8 to cleavage by MMP-13 at 24 °C.
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